Transfers of value in the healthcare sector: transparency becomes a legal obligation in Belgium
This article provides a detailed analysis of the Sunshine Act and the consequences that this act implies for pharmaceutical and medical devices companies.
The Belgian Sunshine Act has been published in the Belgian Official Gazette on 27 December 20161. A few months later, a royal decree implementing the Sunshine Act marked the effective entry into force of the Sunshine Act on 23 June 2017, while providing companies with essential clarifications in terms of scope and operation2.
Click here to read the full article
1 Act of 18 December 2016 on various health-related matters (art. 41 and seq.), B.O.G. 27 December 2016.
2 Royal Decree of 14 June 2017 implementing the Sunshine Act, B.O.G. 23 June 2017.
_11zon.jpg?crop=300,495&format=webply&auto=webp)


_11zon.jpg?crop=300,495&format=webply&auto=webp)





_11zon.jpg?crop=300,495&format=webply&auto=webp)



.jpg?crop=300,495&format=webply&auto=webp)



_11zon.jpg?crop=300,495&format=webply&auto=webp)

_11zon.jpg?crop=300,495&format=webply&auto=webp)